Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
NovoCure Ltd.
ClinicalTrials.gov Identifier:
NCT00379470
First received: September 20, 2006
Last updated: April 29, 2012
Last verified: April 2012